Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Elder MJ, Kilvington S, Dart JK . A clinicopathological study of in vitro sensitivity testing and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 1994;35:1059–64.
Larkin DFP, Easty DL . Experimental Acanthamoeba keratitis. I. Preliminary findings. Br J Ophthalmol 1990;74:551–5.
Neiderkorn JA, Ubelaker JE, McClulley JP, et al. Susceptibility of corneas from various animal species to in vitro binding and invasion by Acanthamoeba castellani. Invest Ophthalmol Vis Sci 1992;33:104–12.
He YG, McCulley JP, Alizadeh H, et al. A pig model of Acanthamoeba keratitis: transmission via contaminated contact lenses. Invest Ophthalmol Vis Sci 1992;33:126–33.
van Klink F, Alizadeh H, He YG, et al. The role of contact lenses, trauma and Langerhans cells in a Chinese hamster model of Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 1993;34:1937–44.
Wright P, Warhurst D, Jones BR . Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol 1985;69:773–82.
Larkin DFP, Kilvington S, Dart JKG . Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 1992;99:185–91.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ruddell, T., Easty, D. Drug therapy in a murine model of Acanthamoeba keratitis. Eye 9, 142–143 (1995). https://doi.org/10.1038/eye.1995.24
Issue date:
DOI: https://doi.org/10.1038/eye.1995.24
